Africa Shouldn’t Only Use Medical Evidence. It Should Help Create It.

Much of the evidence behind treatment decisions in Africa has been generated elsewhere. African patients deserve data that reflects their realities.

At Shalina Healthcare, we’re committed to changing that by investing in clinical research that builds African evidence, in Africa, for Africa.

That’s why we’re proud that four real-world studies from Ghana and the DRC, on hypertension and dyslipidaemia, are now published in the World Journal of Cardiovascular Diseases (Vol. 16, No. 9, 2026).

They were built with African physicians and African patients, in African clinical settings.

Four studies. One clear direction: more African evidence, for African patients.